name: | Tenapanor |
ATC code: | A06AX08 | route: | oral |
n-compartments | 1 |
Tenapanor is an inhibitor of the sodium/hydrogen exchanger 3 (NHE3) located in the intestines, approved for the treatment of adults with irritable bowel syndrome with constipation (IBS-C) and, in some regions, for hyperphosphatemia in chronic kidney disease patients on dialysis.
Healthy adults, both sexes, evaluated after oral administration; tenapanor has minimal systemic absorption, thus systemic exposure is negligible.